← SynDRA
TAK-243
SynDRA canonical compound SYN0039561 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | UBA1 |
| Mechanism of action | ubiquitin activating enzyme inhibitor |
All known targets
Mechanisms of action (all sources)
- ubiquitin activating enzyme inhibitor
Cross-references
Synonyms
- TAK 243
- MLN7243
- UAE INHIBITOR MLN7243
- AOB 87172
- AOB87172
- MLN-7243
- TAK-243 (MLN7243)
- V9GGV0YCDI
- UNII-V9GGV0YCDI
- Uae inhibitor MLN7243
- SCHEMBL15191794
- KJDAGXLMHXUAGV-DGWLBADLSA-N
- Sulfamic acid, ((1R,2R,3S,4R)-2,3-dihydroxy-4-((2-(3-((trifluoromethyl)thio)phenyl)pyrazolo(1,5-a)pyrimidin-7-yl)amino)cyclopentyl)methyl ester
- ((1R,2R,3S,4R)-2,3-dihydroxy-4-(2-(3-(trifluoromethylthio)phenyl)pyrazolo[1,5-a]pyrimidin-7-ylamino)cyclopentyl)methyl sulfamate
- ((1R,2R,3S,4R)-2,3-Dihydroxy-4-((2-(3-(trifluoromethylsulfanyl)phenyl)pyrazolo(1,5-a)pyrimidin-7-yl)amino)cyclopentyl)methyl sulfamate
- MLN 7243
- RefChem:187185
- UAE Inhibitor TAK-243
- MFCD28964160
- orb1307707
- SCHEMBL29904406
- TAK 243 [WHO-DD]
- C19H20F3N5O5S2
- BDBM329836
- GLXC-90204
- EX-A5569
- TAK-243(MLN7243)
- NSC785004
- US9663525, Compound I-044
- US9663525, Compound I-101
- AKOS037648830
- EBC-520387
- NSC-785004
- BS-15752
- BT165712
- DA-58252
- SY292592
- HY-100487
Look up TAK-243 in the interactive SynDRA portal →